Severe coinfection with seasonal influenza A (H3N2) virus and staphylococcus aureus - Maryland, February-March 2012

Morbidity and Mortality Weekly Report

Volumn 61, Issue 16, 2012, Pages 289-291

  O'Brien, Linda ^a   Donegan, Nancy ^b   Flaniken, Ann ^c   Rogers, David ^c   Myers, Robert ^d   Razeq, Jafar ^d   Thompson, Ruth ^d   Jain, Seema ^e   Lindstrom, Stephen ^e   Kallen, Alexander ^f   Said, Maria A ^g   Greenbaum, Adena ^g   Garrett, Tiana ^g  

^a Calvert Memorial Hospital   (United States)

^b WASHINGTON HOSPITAL CENTER   (United States)

^c Calvert County Health Dept   (United States)

^d MARYLAND DEPARTMENT OF HEALTH AND MENTAL HYGIENE   (United States)

^e National Center for Immunizations and Respiratory Diseases   (United States)

^f NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

^g CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; ANTIVIRUS AGENT;

AGED; CASE REPORT; FAMILY HEALTH; FATALITY; HOSPITALIZATION; HUMAN; INFLUENZA; INFLUENZA VIRUS A H3N2; ISOLATION AND PURIFICATION; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MIDDLE AGED; MIXED INFECTION; NOTE; STAPHYLOCOCCUS INFECTION; TREATMENT OUTCOME; UNITED STATES;

AGED; ANTI-BACTERIAL AGENTS; ANTIVIRAL AGENTS; COINFECTION; FAMILY HEALTH; FATAL OUTCOME; HUMANS; INFLUENZA A VIRUS, H3N2 SUBTYPE; INFLUENZA, HUMAN; MARYLAND; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MIDDLE AGED; SEVERITY OF ILLNESS INDEX; STAPHYLOCOCCAL INFECTIONS; TREATMENT OUTCOME;

EID: 84862003898     PISSN: 01492195     EISSN: 1545861X     Source Type: Journal    
DOI: None     Document Type: Note

References (10)

1. Chickering HT, Park JH. Staphylococcus aureus pneumonia. JAMA 1919;72:617-26.
2. Hageman JC, Uyeki TM, Frances JS, et al. Severe community-acquired pneumonia due to Staphylococcus aureus, 2003-04 influenza season. Emerg Infect Dis 2006;12:894-9.
3. Kallen AJ, Brunkard J, Moore Z, et al. Staphylococcus aureus community-acquired pneumonia during the 2006 to 2007 influenza season. Ann Emerg Med 2009;53:358-65.
4. Jones TF, Creech CB, Erwin P, Baird SG, Woron AM, Schaffner W. Family outbreaks of invasive community-associated methicillin-resistantStaphylococcus aureus infection. Clin Infect Dis 2006;42:e76-8.
5. Liu C, Bayer A, Cosgrove S, et al. Clinical practice guidelines by the Infectious Diseases Society of America for the treatment of methicillin-resistantStaphylococcus aureus infections in adults and children. Clin Infect Dis 2011;52:e18-55.
6. Gorwitz R, Kruszon-Moran D, McAllister S, et al. Changes in the prevalence of nasal colonization with Staphylococcus aureus in the United States, 2001-2004. J Infect Dis 2008;197:1226-34.
7. Kallen A, Mu Y, Bulens S, et al. Health care-associated invasive MRSA infections, 2005-2008. JAMA 2010;304:641-8.
8. Limbago B, Fosheim GE, Schoonover V, et al.; Active Bacterial Core surveillance MRSA investigators. Characterization of methicillin-resistantStaphylococcus aureus isolates collected in 2005 and 2006 from patients with invasive disease: a population-based analysis. J Clin Microbiol 2009;47:1344-51.
9. CDC. Antiviral agents for the treatment and chemoprophylaxis of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 2011;60(No. RR-1).
10. Siegel J, Rhinehart E, Jackson M, Chiarello L; Health Care Infection Control Practices Advisory Committee. 2007 guideline for isolation precautions: preventing transmission of infectious agents in health care settings. Am J Infect Control 2007;35(10 Suppl 2):S65-164.